NEC8
Resource Report
Resource Website
1+ mentions
Discontinued
|
JCRB Cat# FDSC0005, RRID:CVCL_1604
|
Homo sapiens (Human)
|
Testicular embryonal carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:520758
PMID:2445169
PMID:3518877
PMID:3618218
PMID:9290701
PMID:20164919
PMID:20215515
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
NEC-8 |
JCRB |
FDSC0005 |
BTO:BTO_0006542,
CLO:CLO_0051391,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03471665,
cancercelllines:CVCL_1604,
Cell_Model_Passport:SIDM00243,
ChEMBL-Cells:CHEMBL3308176,
ChEMBL-Targets:CHEMBL2366340,
Cosmic:910942,
Cosmic-CLP:910942,
DepMap:ACH-002288,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10590-108D5,
GDSC:910942,
GEO:GSM827251,
GEO:GSM1670276,
IARC_TP53:21583,
JCRB:FDSC0005,
JCRB:JCRB0250,
LINCS_LDP:LCL-1900,
PharmacoDB:NEC8_1156_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1604,
PubChem_Cell_line:CVCL_1604,
RCB:RCB0489,
Wikidata:Q54930382 |
|
|
CVCL_1604 |
2026-09-12 05:56:09 |
1 |
NEC8
Resource Report
Resource Website
1+ mentions
Discontinued
|
RRID:CVCL_1604
|
Homo sapiens (Human)
|
Testicular embryonal carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:520758
PMID:2445169
PMID:3518877
PMID:3618218
PMID:9290701
PMID:20164919
PMID:20215515
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
NEC-8 |
|
|
BTO:BTO_0006542,
CLO:CLO_0051391,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03471665,
cancercelllines:CVCL_1604,
Cell_Model_Passport:SIDM00243,
ChEMBL-Cells:CHEMBL3308176,
ChEMBL-Targets:CHEMBL2366340,
Cosmic:910942,
Cosmic-CLP:910942,
DepMap:ACH-002288,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10590-108D5,
GDSC:910942,
GEO:GSM827251,
GEO:GSM1670276,
IARC_TP53:21583,
JCRB:FDSC0005,
JCRB:JCRB0250,
LINCS_LDP:LCL-1900,
PharmacoDB:NEC8_1156_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1604,
PubChem_Cell_line:CVCL_1604,
RCB:RCB0489,
Wikidata:Q54930382 |
|
|
CVCL_1604 |
2026-09-12 05:56:09 |
1 |
NH-12
Resource Report
Resource Website
|
RRID:CVCL_1605
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9290701
PMID:12210830
PMID:18923524
PMID:20164919
PMID:27397505
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
NH12, Neuroblastoma-12 |
|
|
CLO:CLO_0050267,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:966,
BioSample:SAMN01821709,
BioSample:SAMN03472526,
cancercelllines:CVCL_1605,
Cell_Model_Passport:SIDM00577,
ChEMBL-Cells:CHEMBL3308211,
ChEMBL-Targets:CHEMBL2366263,
Cosmic:801745,
Cosmic:908447,
Cosmic:947719,
Cosmic:1037350,
Cosmic:1099147,
Cosmic:1153788,
Cosmic:2131593,
Cosmic-CLP:908447,
DepMap:ACH-001603,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10555-107I6,
GDSC:908447,
GEO:GSM313808,
GEO:GSM333802,
GEO:GSM1670277,
IARC_TP53:21584,
JCRB:JCRB0833,
LINCS_LDP:LCL-1978,
PharmacoDB:NH12_1157_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1605,
PubChem_Cell_line:CVCL_1605,
RCB:RCB2108,
TKG:TKG 0448,
Wikidata:Q54930502 |
|
|
CVCL_1605 |
2026-09-12 05:56:11 |
0 |
NH-12
Resource Report
Resource Website
|
RCB Cat# RCB2108, RRID:CVCL_1605
|
Homo sapiens (Human)
|
Adrenal gland neuroblastoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:9290701
PMID:12210830
PMID:18923524
PMID:20164919
PMID:27397505
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
NH12, Neuroblastoma-12 |
RCB |
RCB2108 |
CLO:CLO_0050267,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioGRID_ORCS_Cell_line:966,
BioSample:SAMN01821709,
BioSample:SAMN03472526,
cancercelllines:CVCL_1605,
Cell_Model_Passport:SIDM00577,
ChEMBL-Cells:CHEMBL3308211,
ChEMBL-Targets:CHEMBL2366263,
Cosmic:801745,
Cosmic:908447,
Cosmic:947719,
Cosmic:1037350,
Cosmic:1099147,
Cosmic:1153788,
Cosmic:2131593,
Cosmic-CLP:908447,
DepMap:ACH-001603,
EGA:EGAS00001000978,
FANTOM5_SSTAR:10555-107I6,
GDSC:908447,
GEO:GSM313808,
GEO:GSM333802,
GEO:GSM1670277,
IARC_TP53:21584,
JCRB:JCRB0833,
LINCS_LDP:LCL-1978,
PharmacoDB:NH12_1157_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1605,
PubChem_Cell_line:CVCL_1605,
RCB:RCB2108,
TKG:TKG 0448,
Wikidata:Q54930502 |
|
|
CVCL_1605 |
2026-09-12 05:56:11 |
0 |
SiHa
Resource Report
Resource Website
1000+ mentions
|
CLS Cat# 305023, RRID:CVCL_0032
|
Homo sapiens (Human)
|
Human papillomavirus-related cervical squamous cell carcinoma
|
Virology: Contains a complete HPV16 genome with a disruption of the E2 region and a small deletion (PubMed=24201445)., Population: Japanese., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:327080
PMID:833871
PMID:1394225
PMID:2990217
PMID:3029430
PMID:3029760
PMID:3518877
PMID:5529598
PMID:10423141
PMID:15531914
PMID:16957166
PMID:17311676
PMID:20164919
PMID:20215515
PMID:20429727
PMID:21439369
PMID:22412903
PMID:23881600
PMID:24134916
PMID:24201445
PMID:25485619
PMID:25877200
PMID:26589293
PMID:27397505
PMID:28261610
PMID:29156801
PMID:30760827
PMID:30894373
PMID:31068700
PMID:35198691
PMID:35421932
PMID:35692560
PMID:35839778
|
Cancer cell line
|
Female |
Siha, SIHA |
CLS |
305023 |
BTO:BTO_0002210,
CLO:CLO_0009017,
EFO:EFO_0002379,
MCCL:MCC:0000451,
CLDB:cl4298,
CLDB:cl4299,
CLDB:cl4900,
AddexBio:C0008002/372,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-35,
BioGRID_ORCS_Cell_line:1796,
BioSample:SAMN03473215,
BioSample:SAMN10989623,
cancercelllines:CVCL_0032,
CCRID:1101HUM-PUMC000294,
CCRID:1102HUM-NIFDC00092,
CCRID:3101HUMSCSP5058,
CCRID:3101HUMTCHu113,
CCRID:4201HUM-CCTCC00110,
CCTCC:GDC0110,
Cell_Model_Passport:SIDM01093,
ChEMBL-Cells:CHEMBL3307968,
ChEMBL-Targets:CHEMBL612542,
CLS:305023,
Cosmic:760220,
Cosmic:809229,
Cosmic:846184,
Cosmic:877467,
Cosmic:925356,
Cosmic:928911,
Cosmic:930297,
Cosmic:1019306,
Cosmic:1131517,
Cosmic:1193028,
Cosmic:1201773,
Cosmic:1324212,
Cosmic:1995627,
Cosmic:2301542,
Cosmic:2660193,
Cosmic:2791018,
Cosmic:2816217,
Cosmic-CLP:930297,
DepMap:ACH-000556,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
GDSC:930297,
GEO:GSM113866,
GEO:GSM226740,
GEO:GSM226876,
GEO:GSM253302,
GEO:GSM675738,
GEO:GSM685444,
GEO:GSM722576,
GEO:GSM722577,
GEO:GSM723057,
GEO:GSM723058,
GEO:GSM1670422,
GEO:GSM1716411,
GEO:GSM1716412,
GEO:GSM1716413,
GEO:GSM1716414,
GEO:GSM1716415,
GEO:GSM1716416,
GEO:GSM1716423,
GEO:GSM1716424,
GEO:GSM1716425,
GEO:GSM1716426,
GEO:GSM7701382,
IARC_TP53:21696,
ICLC:HTL98017,
IGRhCellID:SiHa,
IZSLER:BS TCL 112,
KCB:KCB 2013026YJ,
KCLB:30035,
LINCS_LDP:LCL-1542,
PharmacoDB:SiHa_1377_2019,
PRIDE:PXD001806,
PRIDE:PXD005466,
PRIDE:PXD029773,
PRIDE:PXD030304,
PRIDE:PXD030885,
Progenetix:CVCL_0032,
PubChem_Cell_line:CVCL_0032,
TOKU-E:3119,
Wikidata:Q54953470 |
|
|
CVCL_0032 |
2026-09-12 06:06:34 |
1434 |
LNZTA3WT4
Resource Report
Resource Website
1+ mentions
Discontinued
|
ATCC Cat# CRL-11543, RRID:CVCL_3540
|
Homo sapiens (Human)
|
Astrocytoma
|
Characteristics: Transfected with the tetracycline transactivator (tTA) protein, a fusion of tetR with the activation domain of HSV-1 VP16., Characteristics: The expression of the luciferase reporter gene as well as the TP53 gene are under the control of a tetO operator., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:27397505
PMID:30894373
PMID:30971826
PMID:35839778
|
Cancer cell line
|
Male |
LNZTA3p53WT4, WT4 |
ATCC |
CRL-11543 |
CLO:CLO_0007371,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-11543,
BioGRID_ORCS_Cell_line:931,
BioSample:SAMN03471340,
cancercelllines:CVCL_3540,
Cell_Model_Passport:SIDM01220,
Cosmic:1995487,
Cosmic-CLP:1240170,
DepMap:ACH-002269,
EGA:EGAS00001000978,
GDSC:1240170,
GEO:GSM1670052,
LINCS_HMS:50028,
LINCS_LDP:LCL-1345,
PharmacoDB:LNZTA3WT4_853_2019,
PRIDE:PXD030304,
Wikidata:Q54902866 |
cvcl_0394 |
|
CVCL_3540 |
2026-09-12 06:16:13 |
1 |
RWPE-1
Resource Report
Resource Website
500+ mentions
|
ATCC Cat# CRL-3607, RRID:CVCL_3791
|
Homo sapiens (Human)
|
|
Population: Caucasian., Part of: ENCODE project common cell types; tier 3., Group: Patented cell line.
|
PMID:8977636
PMID:9214605
PMID:9214606
PMID:20215515
PMID:22275356
PMID:25877200
PMID:27397505
PMID:30305041
PMID:30787054
|
Transformed cell line
|
Male |
RWPE1 |
ATCC |
CRL-3607 |
BTO:BTO_0003709,
CLO:CLO_0008905,
EFO:EFO_0002323,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-3607,
ATCC:CRL-11609,
BCRJ:0389,
BioSample:SAMN03470832,
BioSample:SAMN05292437,
BioSample:SAMN07709991,
BioSample:SAMN07709992,
BioSample:SAMN07709993,
BioSample:SAMN07709994,
BioSample:SAMN07709995,
BioSample:SAMN07709996,
BioSample:SAMN07709997,
cancercelllines:CVCL_3791,
CCRID:3101HUMGNHu37,
CCRID:3101HUMSCSP5025,
CCRID:4201HUM-CCTCC00178,
CCTCC:GDC0178,
Cell_Model_Passport:SIDM00020,
ChEMBL-Cells:CHEMBL4295468,
ChEMBL-Targets:CHEMBL4296492,
CLS:305217,
EGA:EGAS00001000978,
ENCODE:ENCBS124FCL,
ENCODE:ENCBS192LWI,
ENCODE:ENCBS263AAA,
ENCODE:ENCBS875FPF,
GEO:GSM827387,
GEO:GSM1008595,
GEO:GSM1374860,
GEO:GSM1670396,
IGRhCellID:RWPE1,
Lonza:870,
PharmacoDB:RWPE1_1336_2019,
Progenetix:CVCL_3791,
PubChem_Cell_line:CVCL_3791,
Wikidata:Q54951497 |
|
|
CVCL_3791 |
2026-09-12 06:16:52 |
738 |
NK-92MI
Resource Report
Resource Website
10+ mentions
Possibly Discontinued
Discontinued
|
KCB Cat# KCB 200677YJ, RRID:CVCL_3755
|
Homo sapiens (Human)
|
Natural killer cell lymphoblastic leukemia/lymphoma
|
Caution: This cell line is exclusively owned and controlled by NantKwest, Inc. NantKwest and its affiliate, Brink Biologics, Inc. are the sole authorized distributors for both commercial and non-commercial research requestors. There are no other authorized commercial and non-commercial suppliers of NK-92MI. Contact NantKwest and Brink Biologics for information concerning current inventory and cell line use and support., Characteristics: No longer dependent on IL2., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10365666
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
NK-92 MI, NK-92 mi, NK92-MI, NK92MI, NK-92 transfected with MFG-hIL2 |
KCB |
KCB 200677YJ |
CLO:CLO_0008178,
ATCC:CRL-2408,
BCRC:60438,
cancercelllines:CVCL_3755,
CCRID:1102HUM-NIFDC00065,
Cell_Model_Passport:SIDM01201,
Cosmic-CLP:1330981,
DepMap:ACH-002289,
GDSC:1330981,
GEO:GSM1670278,
KCB:KCB 200677YJ,
LINCS_LDP:LCL-1127,
PharmacoDB:NK92MI_1160_2019,
PRIDE:PXD030304,
Wikidata:Q54930658 |
cvcl_2142 |
|
CVCL_3755 |
2026-09-12 06:16:22 |
24 |
TOV-21G
Resource Report
Resource Website
10+ mentions
Possibly Discontinued
|
RRID:CVCL_3613
|
Homo sapiens (Human)
|
Ovarian clear cell adenocarcinoma
|
Population: Caucasian., Part of: PTEN genetic alteration cell panel (ATCC TCP-1030)., Part of: OCCP ovarian cancer cell line panel., Part of: MD Anderson Cell Lines Project., Part of: KuDOS 95 cell line panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Patented cell line.
|
PMID:10949993
PMID:11641787
PMID:19058220
PMID:20081105
PMID:20204287
PMID:22460905
PMID:22705003
PMID:22710073
PMID:23839242
PMID:24023729
PMID:24224046
PMID:25230021
PMID:25877200
PMID:25960936
PMID:25984343
PMID:26388441
PMID:26589293
PMID:27397505
PMID:28196595
PMID:28273451
PMID:30485824
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
TOV-21g, TOV21G, TOV21 |
|
|
BTO:BTO_0005183,
CLO:CLO_0009385,
EFO:EFO_0022427,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-3577,
ATCC:CRL-11730,
BCRC:60407,
BCRJ:0236,
BioGRID_ORCS_Cell_line:446,
BioSample:SAMN02800401,
BioSample:SAMN03471875,
BioSample:SAMN10988233,
cancercelllines:CVCL_3613,
CancerTools:161764,
Cell_Model_Passport:SIDM01169,
ChEMBL-Cells:CHEMBL4630710,
ChEMBL-Targets:CHEMBL4630716,
Cosmic:1066220,
Cosmic:1102820,
Cosmic:1139221,
Cosmic:1223320,
Cosmic:1305319,
Cosmic:1312195,
Cosmic:1328069,
Cosmic:1434896,
Cosmic:1449932,
Cosmic:1707558,
Cosmic:1708383,
Cosmic:2074249,
Cosmic-CLP:1240222,
DepMap:ACH-000885,
EGA:EGAS00001000978,
GDSC:1240222,
GEO:GSM289385,
GEO:GSM289386,
GEO:GSM289416,
GEO:GSM289417,
GEO:GSM313692,
GEO:GSM416684,
GEO:GSM659408,
GEO:GSM784567,
GEO:GSM851945,
GEO:GSM887711,
GEO:GSM888804,
GEO:GSM1176285,
GEO:GSM1291153,
GEO:GSM1374965,
GEO:GSM1670547,
GEO:GSM2475008,
IARC_TP53:21094,
LiGeA:CCLE_476,
LINCS_LDP:LCL-1530,
PharmacoDB:TOV21G_1605_2019,
PRIDE:PXD000901,
PRIDE:PXD030304,
Progenetix:CVCL_3613,
PubChem_Cell_line:CVCL_3613,
Wikidata:Q54972808 |
|
|
CVCL_3613 |
2026-09-12 06:02:30 |
28 |
TT2609-C02
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_2218
|
Homo sapiens (Human)
|
Thyroid gland follicular carcinoma
|
Karyotypic information: Near tetraploid karyotype (PubMed=11716037)., Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11716037
PMID:18713817
PMID:22460905
PMID:23833040
PMID:25675381
PMID:26589293
PMID:27397505
PMID:29066502
PMID:30737244
PMID:30894373
PMID:31068700
PMID:31443247
PMID:35839778
|
Cancer cell line
|
Male |
TT2609-CO2, TT2609C02 |
|
|
CLO:CLO_0037156,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03473513,
BioSample:SAMN10989561,
cancercelllines:CVCL_2218,
Cell_Model_Passport:SIDM00418,
Cosmic:1995660,
Cosmic:2054095,
Cosmic-CLP:1240223,
DepMap:ACH-000716,
DSMZ:ACC-510,
DSMZCellDive:ACC-510,
EGA:EGAS00001000978,
GDSC:1240223,
GEO:GSM887712,
GEO:GSM888805,
GEO:GSM1670550,
IARC_TP53:28237,
LiGeA:CCLE_442,
LINCS_LDP:LCL-1681,
PharmacoDB:TT2609C02_1607_2019,
PRIDE:PXD030304,
Progenetix:CVCL_2218,
Wikidata:Q54973225 |
|
|
CVCL_2218 |
2026-09-12 06:02:41 |
2 |
TT
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1774
|
Homo sapiens (Human)
|
Hereditary thyroid gland medullary carcinoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:1516062
PMID:2519210
PMID:3467830
PMID:7736432
PMID:7864888
PMID:9046062
PMID:11751535
PMID:19897677
PMID:20164919
PMID:20215515
PMID:22460905
PMID:22538498
PMID:26589293
PMID:27397505
PMID:30737244
PMID:30894373
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
MTC-TT |
|
|
BTO:BTO_0003074,
CLO:CLO_0009421,
EFO:EFO_0002382,
CLDB:cl4547,
CLDB:cl4901,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-1803,
BCRC:60346,
BCRJ:0259,
BioSample:SAMN03471250,
BioSample:SAMN10988442,
cancercelllines:CVCL_1774,
CCRID:1101HUM-PUMC000268,
CCRID:3101HUMTCHu78,
CCRID:4201HUM-CCTCC00073,
CCTCC:GDC0073,
Cell_Model_Passport:SIDM00484,
ChEMBL-Cells:CHEMBL3308145,
ChEMBL-Targets:CHEMBL2366083,
CLS:305027,
Cosmic:796049,
Cosmic:796731,
Cosmic:930299,
Cosmic:1005455,
Cosmic:1094763,
Cosmic:1175889,
Cosmic:1239955,
Cosmic:1608835,
Cosmic:1612901,
Cosmic:1699419,
Cosmic:1876248,
Cosmic:2036697,
Cosmic:2050374,
Cosmic-CLP:930299,
DepMap:ACH-001321,
ECACC:92050721,
EGA:EGAS00001000978,
GDSC:930299,
GEO:GSM887714,
GEO:GSM888807,
GEO:GSM1374966,
GEO:GSM1670548,
IARC_TP53:27017,
IARC_TP53:30182,
ICLC:HTL98004,
IGRhCellID:TT,
KCB:KCB 2013001YJ,
LiGeA:CCLE_452,
LINCS_LDP:LCL-1690,
Lonza:1097,
PharmacoDB:TT_1606_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1774,
PubChem_Cell_line:CVCL_1774,
Wikidata:Q54973178 |
|
|
CVCL_1774 |
2026-09-12 06:02:39 |
6 |
TUR
Resource Report
Resource Website
|
RRID:CVCL_1775
|
Homo sapiens (Human)
|
Adult acute monocytic leukemia
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:7720732
PMID:8398907
PMID:20164919
PMID:27397505
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Male |
TPA-U937-resistant |
|
|
CLO:CLO_0009447,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-2367,
BioSample:SAMN03471833,
cancercelllines:CVCL_1775,
Cell_Model_Passport:SIDM01205,
ChEMBL-Cells:CHEMBL3308519,
ChEMBL-Targets:CHEMBL2366218,
Cosmic:683549,
Cosmic:909773,
Cosmic-CLP:909773,
DepMap:ACH-002314,
EGA:EGAS00001000978,
GDSC:909773,
GEO:GSM186464,
GEO:GSM1670551,
IARC_TP53:27263,
LINCS_LDP:LCL-2063,
PharmacoDB:TUR_1613_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1775,
PubChem_Cell_line:CVCL_1775,
Wikidata:Q54973376 |
cvcl_0007 |
|
CVCL_1775 |
2026-09-12 06:02:44 |
0 |
U-118MG
Resource Report
Resource Website
1000+ mentions
Contaminated
Discontinued
|
RRID:CVCL_0633
|
Homo sapiens (Human)
|
Astrocytoma
|
Population: Caucasian., Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982)., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Contaminated. Shown to be a U-138MG derivative (PubMed=20143388)..
|
PMID:327080
PMID:450131
PMID:833871
PMID:2253244
PMID:2454731
PMID:3518877
PMID:3675803
PMID:4134536
PMID:4312117
PMID:4313504
PMID:4337530
PMID:4369403
PMID:6220172
PMID:6260907
PMID:7017212
PMID:7459858
PMID:9220028
PMID:10402232
PMID:10416987
PMID:10560660
PMID:11414198
PMID:16697959
PMID:19365568
PMID:19435942
PMID:20143388
PMID:20164919
PMID:22460905
PMID:22570425
PMID:27397505
PMID:27582061
PMID:30894373
PMID:31068700
PMID:31978347
PMID:35839778
|
Cancer cell line
|
Male |
U-118 MG, U-118-MG, U118-MG, U118MG, U118, 118 MG, 118MG |
|
|
BTO:BTO_0004605,
CLO:CLO_0009451,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:CRL-7712,
ATCC:HTB-15,
BioGRID_ORCS_Cell_line:445,
BioSample:SAMN03151974,
BioSample:SAMN03472723,
BioSample:SAMN10988042,
cancercelllines:CVCL_0633,
CCRID:3101HUMTCHu216,
Cell_Model_Passport:SIDM01193,
ChEMBL-Cells:CHEMBL3308793,
ChEMBL-Targets:CHEMBL1075602,
CLS:300362,
Cosmic:687588,
Cosmic:849852,
Cosmic:849878,
Cosmic:920817,
Cosmic:1175822,
Cosmic:1217672,
Cosmic:1571919,
Cosmic:1610738,
Cosmic:2301554,
Cosmic:2367553,
Cosmic:2550362,
Cosmic:2668299,
Cosmic:2701084,
Cosmic-CLP:687588,
DepMap:ACH-000040,
EGA:EGAS00001000978,
GDSC:687588,
GEO:GSM101671,
GEO:GSM101672,
GEO:GSM888812,
GEO:GSM1374968,
GEO:GSM1374969,
GEO:GSM1670554,
IARC_TP53:4195,
KCB:KCB 2013002YJ,
LiGeA:CCLE_075,
LINCS_LDP:LCL-1358,
PharmacoDB:U118MG_1616_2019,
PRIDE:PXD030304,
Progenetix:CVCL_0633,
PubChem_Cell_line:CVCL_0633,
Wikidata:Q54973503 |
cvcl_0020 |
|
CVCL_0633 |
2026-09-12 06:02:46 |
1987 |
U-87MG ATCC
Resource Report
Resource Website
1000+ mentions
Misidentified
Discontinued
|
RRID:CVCL_0022
|
Homo sapiens (Human)
|
Glioblastoma
|
Population: Caucasian., Part of: Human Protein Atlas, Cell Atlas panel., Part of: ENCODE project common cell types; tier 3., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Problematic cell line: Misidentified. This cell line is not the original glioblastoma cell line established in 1968 at the University of Uppsala. As described in PubMed=27582061 it is most probably also a glioblastoma cell line but whose origin is unknow. See U-87MG Uppsala (Cellosaurus=CVCL_GP63) for the original U-87MG cell line..
|
PMID:327080
PMID:450131
PMID:833871
PMID:3518877
PMID:7459858
PMID:7763724
PMID:8069455
PMID:9090379
PMID:9230885
PMID:9842975
PMID:10074188
PMID:10402232
PMID:10416987
PMID:10560660
PMID:11414198
PMID:11416159
PMID:11966317
PMID:14614447
PMID:14655754
PMID:14961077
PMID:16232199
PMID:16697959
PMID:17595512
PMID:19365568
PMID:19435942
PMID:20126413
PMID:20164919
PMID:20215515
PMID:20587068
PMID:20593219
PMID:21406405
PMID:22282976
PMID:22460905
PMID:22570425
PMID:23325432
PMID:25877200
PMID:25894527
PMID:25960936
PMID:25984343
PMID:26496030
PMID:26589293
PMID:27397505
PMID:27412690
PMID:27582061
PMID:27894925
PMID:30894373
PMID:30971826
PMID:31068700
PMID:31978347
PMID:33385022
|
Cancer cell line
|
Male |
U-87MG, U-87 MG, U87 MG, U-87-MG, U87-MG, U87MG, U-87, U87, 87 MG, 87MG |
|
|
BTO:BTO_0002036,
CLO:CLO_0009463,
CLO:CLO_0009464,
EFO:EFO_0005237,
MCCL:MCC:0000469,
CLDB:cl4592,
CLDB:cl4594,
CLDB:cl4595,
CLDB:cl7166,
Abcam:ab278079,
AddexBio:C0005002/71,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ATCC:HTB-14,
BCRC:60360,
BCRJ:0241,
BEI_Resources:ARP-2188,
BioGRID_ORCS_Cell_line:348,
BioSample:SAMN03472715,
BioSample:SAMN03473126,
BioSample:SAMN05292456,
BioSample:SAMN07710026,
BioSample:SAMN07710027,
BioSample:SAMN07710028,
BioSample:SAMN07710029,
BioSample:SAMN07710030,
BioSample:SAMN07710031,
BioSample:SAMN07710032,
BioSample:SAMN10988360,
cancercelllines:CVCL_0022,
CCRID:1101HUM-PUMC000208,
CCRID:3101HUMTCHu138,
CCTCC:GDC0157,
Cell_Model_Passport:SIDM01189,
CGH-DB:157-1,
ChEMBL-Cells:CHEMBL3307575,
ChEMBL-Cells:CHEMBL3989361,
ChEMBL-Targets:CHEMBL614247,
CLS:300367,
Cosmic:687590,
Cosmic:849853,
Cosmic:850741,
Cosmic:850822,
Cosmic:920816,
Cosmic:1036336,
Cosmic:1064099,
Cosmic:1066234,
Cosmic:1171224,
Cosmic:1175825,
Cosmic:1198263,
Cosmic:1217671,
Cosmic:1219449,
Cosmic:1237542,
Cosmic:1294951,
Cosmic:1610737,
Cosmic:1746951,
Cosmic:1945859,
Cosmic:2302316,
Cosmic:2367555,
Cosmic:2491106,
Cosmic:2516044,
Cosmic:2550364,
Cosmic:2568870,
Cosmic:2580918,
Cosmic:2701083,
Cosmic-CLP:687590,
DepMap:ACH-000075,
ECACC:89081402,
EGA:EGAS00001000978,
ENCODE:ENCBS424ENC,
GDSC:687590,
GEO:GSM101676,
GEO:GSM101686,
GEO:GSM101687,
GEO:GSM101688,
GEO:GSM326243,
GEO:GSM481417,
GEO:GSM500897,
GEO:GSM887723,
GEO:GSM888817,
GEO:GSM923437,
GEO:GSM1374974,
GEO:GSM1638668,
GEO:GSM1670559,
GEO:GSM2113436,
GEO:GSM2113437,
GEO:GSM2113438,
GEO:GSM2113439,
GEO:GSM7701418,
GEO:GSM7701419,
IARC_TP53:21096,
IBRC:C10982,
ICLC:HTL00013,
IZSLER:BS TCL 189,
KCB:KCB 2011101YJ,
KCLB:30014,
LiGeA:CCLE_552,
LINCS_HMS:50868,
LINCS_LDP:LCL-1364,
Lonza:37,
Lonza:808,
MetaboLights:MTBLS4708,
MetaboLights:MTBLS6212,
NCBI_Iran:C531,
PharmacoDB:U87MG_1623_2019,
PRIDE:PXD000589,
PRIDE:PXD000661,
PRIDE:PXD001565,
PRIDE:PXD003790,
Progenetix:CVCL_0022,
PubChem_Cell_line:CVCL_0022,
RCB:RCB0419,
TOKU-E:3381,
Ubigene:YC-C028,
Wikidata:Q7863603 |
|
|
CVCL_0022 |
2026-09-12 06:02:47 |
3470 |
U-CH2
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_4989
|
Homo sapiens (Human)
|
Sacral chordoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:21253487
PMID:26183925
PMID:27102572
PMID:27397505
PMID:28515451
PMID:28835717
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
UCH-2, UCH2 |
|
|
ATCC:CRL-3218,
Cell_Model_Passport:SIDM01185,
Cosmic:2663858,
Cosmic-CLP:1503373,
DepMap:ACH-002204,
DSMZ:ACC-749,
DSMZCellDive:ACC-749,
GEO:GSM1670565,
GEO:GSM1673847,
GEO:GSM1673848,
PharmacoDB:UCH2_1627_2019,
PRIDE:PXD030304,
Wikidata:Q54973617 |
|
|
CVCL_4989 |
2026-09-12 06:02:48 |
3 |
U-CH2
Resource Report
Resource Website
1+ mentions
|
ATCC Cat# CRL-3218, RRID:CVCL_4989
|
Homo sapiens (Human)
|
Sacral chordoma
|
Population: Caucasian., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:21253487
PMID:26183925
PMID:27102572
PMID:27397505
PMID:28515451
PMID:28835717
PMID:30894373
PMID:35839778
|
Cancer cell line
|
Female |
UCH-2, UCH2 |
ATCC |
CRL-3218 |
ATCC:CRL-3218,
Cell_Model_Passport:SIDM01185,
Cosmic:2663858,
Cosmic-CLP:1503373,
DepMap:ACH-002204,
DSMZ:ACC-749,
DSMZCellDive:ACC-749,
GEO:GSM1670565,
GEO:GSM1673847,
GEO:GSM1673848,
PharmacoDB:UCH2_1627_2019,
PRIDE:PXD030304,
Wikidata:Q54973617 |
|
|
CVCL_4989 |
2026-09-12 06:02:48 |
3 |
TGBC11TKB
Resource Report
Resource Website
|
RRID:CVCL_1768
|
Homo sapiens (Human)
|
Gastric carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE).
|
PMID:11416159
PMID:20164919
PMID:22460905
PMID:26589293
PMID:27397505
PMID:30894373
PMID:30971826
PMID:31068700
PMID:35839778
|
Cancer cell line
|
Female |
TGBC-11-TKB, TGBC11T |
|
|
CLO:CLO_0050801,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472160,
BioSample:SAMN10987739,
cancercelllines:CVCL_1768,
Cell_Model_Passport:SIDM00251,
ChEMBL-Cells:CHEMBL3308557,
ChEMBL-Targets:CHEMBL2366374,
Cosmic:909770,
Cosmic:1187297,
Cosmic:1518259,
Cosmic-CLP:909770,
DepMap:ACH-000949,
EGA:EGAS00001000978,
GDSC:909770,
GEO:GSM887705,
GEO:GSM888798,
GEO:GSM1670539,
IARC_TP53:27260,
LiGeA:CCLE_473,
LINCS_LDP:LCL-1892,
PharmacoDB:TGBC11TKB_1589_2019,
PRIDE:PXD030304,
Progenetix:CVCL_1768,
PubChem_Cell_line:CVCL_1768,
RCB:RCB1148,
Wikidata:Q54972233 |
|
|
CVCL_1768 |
2026-09-12 06:02:13 |
0 |
TGBC1TKB
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1769
|
Homo sapiens (Human)
|
Gallbladder undifferentiated carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: Biliary tract cancer cell line atlas.
|
PMID:9824643
PMID:20164919
PMID:21451941
PMID:21533411
PMID:27397505
PMID:30894373
PMID:32293552
PMID:32899426
PMID:35839778
PMID:39026794
|
Cancer cell line
|
Female |
TGBC-1-TKB, TGBC-1TKB, TGBC1-TKB, TGBC-1, TGBC1 |
|
|
CLO:CLO_0050019,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472156,
Cell_Model_Passport:SIDM00252,
ChEMBL-Cells:CHEMBL3308852,
ChEMBL-Targets:CHEMBL2366089,
Cosmic:909769,
Cosmic-CLP:909769,
DepMap:ACH-001861,
EGA:EGAS00001000978,
GDSC:909769,
GEO:GSM1670540,
IARC_TP53:27261,
LINCS_LDP:LCL-1343,
PharmacoDB:TGBC1TKB_1590_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1769,
RCB:RCB1129,
Wikidata:Q54972238 |
|
|
CVCL_1769 |
2026-09-12 06:02:13 |
1 |
TGBC24TKB
Resource Report
Resource Website
1+ mentions
|
RRID:CVCL_1770
|
Homo sapiens (Human)
|
Gallbladder carcinoma
|
Population: Japanese., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Part of: Biliary tract cancer cell line atlas.
|
PMID:20164919
PMID:21451941
PMID:27397505
PMID:30894373
PMID:32899426
PMID:35839778
PMID:39026794
|
Cancer cell line
|
Female |
TGBC-24-TKB, YoMi |
|
|
CLO:CLO_0050018,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-3610,
BioSample:SAMN03472177,
cancercelllines:CVCL_1770,
Cell_Model_Passport:SIDM00267,
ChEMBL-Cells:CHEMBL3308856,
ChEMBL-Targets:CHEMBL2366093,
Cosmic:910695,
Cosmic:2629285,
Cosmic-CLP:910695,
DepMap:ACH-002312,
EGA:EGAS00001000978,
GDSC:910695,
GEO:GSM1670541,
IARC_TP53:27262,
LINCS_LDP:LCL-1344,
PharmacoDB:TGBC24TKB_1591_2019,
PRIDE:PXD030304,
PubChem_Cell_line:CVCL_1770,
RCB:RCB1196,
Wikidata:Q54972239 |
|
|
CVCL_1770 |
2026-09-12 06:02:13 |
1 |
THP-1
Resource Report
Resource Website
10000+ mentions
|
RRID:CVCL_0006
|
Homo sapiens (Human)
|
Childhood acute monocytic leukemia
|
Caution: NRAS mutation indicated incorrectly as being p.Gly12Ser in PubMed=9379676., Anecdotal: Have been flown in space on Cosmos-2044 to study the inhibition of phorbol ester-induced cell activation in microgravity (PubMed=1915666)., Virology: Not susceptible to infection by SARS coronavirus 2 (SARS-CoV-2) (COVID-19) (PubMed=33389257)., Characteristics: Can differentiate from monocytes into macrophage-like cells upon stimulation with PMA., Biotechnology: Used in the human Cell Line Activation Test (h-CLAT), an in vitro skin sensitization test (PubMed=16311011; PubMed=16337770; PubMed=29901211)., Population: Japanese., Part of: Tumor Immunology Bank (TIB) collection from Salk (transferred to ATCC in 1981)., Part of: RAS genetic alteration cell panel (ATCC TCP-1031)., Part of: MD Anderson Cell Lines Project., Part of: LL-100 blood cancer cell line panel., Part of: Human Protein Atlas, Cell Atlas panel., Part of: COSMIC cell lines project., Part of: Cancer Dependency Map project (DepMap) (includes Cancer Cell Line Encyclopedia - CCLE)., Group: Space-flown cell line (cellonaut).
|
PMID:1571549
PMID:1915666
PMID:2633408
PMID:2985879
PMID:3159941
PMID:3874327
PMID:6091813
PMID:6949641
PMID:6970727
PMID:8558913
PMID:9290701
PMID:9379676
PMID:9510473
PMID:9738977
PMID:10223614
PMID:10739008
PMID:11066077
PMID:11226526
PMID:11414198
PMID:11416159
PMID:12068308
PMID:14504097
PMID:14671638
PMID:15843827
PMID:16311011
PMID:16337770
PMID:16408098
PMID:16957166
PMID:19220422
PMID:19377474
PMID:20215515
PMID:22460905
PMID:22481983
PMID:22645513
PMID:22674354
PMID:23097634
PMID:23955599
PMID:24368162
PMID:25130606
PMID:25485619
PMID:25877200
PMID:25984343
PMID:26421875
PMID:26589293
PMID:27397505
PMID:28109323
PMID:28196595
PMID:28404994
PMID:29169185
PMID:29787063
PMID:29901211
PMID:30285677
PMID:30629668
PMID:30894373
PMID:31068700
PMID:31160637
PMID:31978347
PMID:32387766
PMID:33389257
PMID:35373342
PMID:35839778
PMID:36982453
|
Cancer cell line
|
Male |
THP1, THP 1, THPI, THP-1(ATCC), THP-1-O, O-THP-1, Tohoku Hospital Pediatrics-1 |
|
|
BTO:BTO_0001370,
CLO:CLO_0009348,
CLO:CLO_0050999,
EFO:EFO_0001253,
MCCL:MCC:0000461,
CLDB:cl4513,
CLDB:cl4514,
CLDB:cl4515,
CLDB:cl4517,
Abcam:ab271147,
Abcam:ab275477,
Abcam:ab281894,
AddexBio:C0003024/4956,
ArrayExpress:E-MTAB-38,
ArrayExpress:E-MTAB-783,
ArrayExpress:E-MTAB-2706,
ArrayExpress:E-MTAB-2770,
ArrayExpress:E-MTAB-3610,
ArrayExpress:E-MTAB-7721,
ArrayExpress:E-MTAB-7722,
ATCC:TIB-202,
BCRC:60430,
BCRJ:0234,
BEI_Resources:ARP-9942,
BioGRID_ORCS_Cell_line:220,
BioSample:SAMN03470795,
BioSample:SAMN03473256,
BioSample:SAMN03473419,
BioSample:SAMN10987847,
cancercelllines:CVCL_0006,
CCRID:1101HUM-PUMC000057,
CCRID:1102HUM-NIFDC00058,
CCRID:3101HUMSCSP567,
CCRID:3101HUMTCHu57,
CCRID:4201HUM-CCTCC00100,
CCTCC:GDC0100,
Cell_Model_Passport:SIDM01172,
ChEMBL-Cells:CHEMBL3307574,
ChEMBL-Targets:CHEMBL614245,
CLS:300356,
Cosmic:717684,
Cosmic:724818,
Cosmic:787480,
Cosmic:909771,
Cosmic:919122,
Cosmic:924051,
Cosmic:947361,
Cosmic:975303,
Cosmic:991556,
Cosmic:996316,
Cosmic:998748,
Cosmic:1012124,
Cosmic:1037666,
Cosmic:1070694,
Cosmic:1078722,
Cosmic:1089517,
Cosmic:1150901,
Cosmic:1176587,
Cosmic:1181604,
Cosmic:1187864,
Cosmic:1197931,
Cosmic:1278779,
Cosmic:1281356,
Cosmic:1319551,
Cosmic:1476425,
Cosmic:1519163,
Cosmic:1524842,
Cosmic:1601064,
Cosmic:1604863,
Cosmic:2089655,
Cosmic:2131559,
Cosmic:2306241,
Cosmic:2392976,
Cosmic-CLP:909771,
DepMap:ACH-000146,
DSMZ:ACC-16,
DSMZCellDive:ACC-16,
ECACC:88081201,
EGA:EGAS00001000610,
EGA:EGAS00001000978,
ENCODE:ENCBS248PAQ,
ENCODE:ENCBS443IYN,
ENCODE:ENCBS461BPB,
ENCODE:ENCBS615XLU,
ENCODE:ENCBS913QYS,
ENCODE:ENCBS980LBL,
FANTOM5_SSTAR:10399-106A3,
FANTOM5_SSTAR:10400-106A4,
FANTOM5_SSTAR:10405-106A9,
GDSC:909771,
GEO:GSM236807,
GEO:GSM236843,
GEO:GSM482495,
GEO:GSM838432,
GEO:GSM838433,
GEO:GSM887706,
GEO:GSM888799,
GEO:GSM1374962,
GEO:GSM1446742,
GEO:GSM1670543,
GEO:GSM2141952,
GEO:GSM2141956,
GEO:GSM2141958,
GEO:GSM2141959,
GEO:GSM2141962,
GEO:GSM2141968,
GEO:GSM2141972,
GEO:GSM2141974,
GEO:GSM2141979,
GEO:GSM2141986,
GEO:GSM2141987,
GEO:GSM2141993,
GEO:GSM2141995,
GEO:GSM2141998,
GEO:GSM2141999,
GEO:GSM2142000,
GEO:GSM2142004,
GEO:GSM2142005,
GEO:GSM2142009,
GEO:GSM2142011,
GEO:GSM2142015,
GEO:GSM2142016,
GEO:GSM2142019,
GEO:GSM2142021,
GEO:GSM2142023,
GEO:GSM2142024,
GEO:GSM2142028,
GEO:GSM2142029,
GEO:GSM2142030,
GEO:GSM2142031,
GEO:GSM2142036,
GEO:GSM2142037,
GEO:GSM2142039,
GEO:GSM2142048,
GEO:GSM2142049,
GEO:GSM2142052,
GEO:GSM2142053,
GEO:GSM2142055,
GEO:GSM2142059,
GEO:GSM2142060,
GEO:GSM7701404,
GEO:GSM7701405,
IARC_TP53:2198,
ICLC:HTL97014,
IGRhCellID:THP1,
IZSLER:BS TCL 138,
JCRB:JCRB0112,
JCRB:JCRB0112.1,
KCB:KCB 200549YJ,
KCLB:40202,
LiGeA:CCLE_181,
LINCS_HMS:50861,
LINCS_LDP:LCL-1072,
Lonza:134,
MeSH:D000074084,
NCBI_Iran:C563,
PharmacoDB:THP1_1593_2019,
PRIDE:PRD000345,
PRIDE:PXD000328,
PRIDE:PXD000953,
PRIDE:PXD004034,
PRIDE:PXD008516,
PRIDE:PXD011690,
PRIDE:PXD015039,
PRIDE:PXD030304,
Progenetix:CVCL_0006,
PubChem_Cell_line:CVCL_0006,
RCB:RCB1189,
RCB:RCB3686,
TKG:TKG 0267,
Ubigene:YC-D011,
Wikidata:Q7670282 |
|
|
CVCL_0006 |
2026-09-12 06:02:15 |
11783 |
